Castle Biosciences Inc’s filing revealed that its Pres. & Chief Exec. Officer MAETZOLD DEREK J unloaded Company’s shares for reported $0.11 million on Nov 12 ’24. In the deal valued at $34.15 per share,3,155 shares were sold. As a result of this transaction, MAETZOLD DEREK J now holds 6,151 shares worth roughly $0.17 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, MAETZOLD DEREK J sold 1,972 shares, generating $67,344 in total proceeds. Upon selling the shares at $34.15, the Pres. & Chief Exec. Officer now owns 87,720 shares.
Before that, Stokes Frank bought 6,923 shares. Castle Biosciences Inc shares valued at $217,936 were divested by the Officer at a price of $31.48 per share.
Guggenheim initiated its Castle Biosciences Inc [CSTL] rating to a Buy in a research note published on December 14, 2023; the price target was $25. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early January with a ‘”a Sector outperform”‘ rating. Stephens began covering CSTL with “an Overweight” recommendation on January 07, 2022. Lake Street started covering the stock on April 30, 2021. It rated CSTL as “a Buy”.
Price Performance Review of CSTL
On Friday, Castle Biosciences Inc [NASDAQ:CSTL] saw its stock fall -8.86% to $28.10. Over the last five days, the stock has lost -15.59%. Castle Biosciences Inc shares have risen nearly 30.21% since the year began. Nevertheless, the stocks have risen 46.20% over the past one year. While a 52-week high of $35.84 was reached on 11/05/24, a 52-week low of $16.97 was recorded on 07/05/24. SMA at 50 days reached $31.14, while 200 days put it at $24.88.
Levels Of Support And Resistance For CSTL Stock
The 24-hour chart illustrates a support level at 27.20, which if violated will result in even more drops to 26.31. On the upside, there is a resistance level at 29.81. A further resistance level may holdings at 31.53. The Relative Strength Index (RSI) on the 14-day chart is 35.44, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.43, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.98%. Stochastics %K at 7.48% indicates the stock is a buying.
How much short interest is there in Castle Biosciences Inc?
A steep rise in short interest was recorded in Castle Biosciences Inc stocks on 2024-10-31, dropping by 6631.0 shares to a total of 1.61 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 1.61 million shares. There was a decline of -0.41%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 10, 2020 when KeyBanc Capital Markets began covering the stock and recommended ‘”an Overweight”‘ rating along with a $70 price target.
